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718Background: From 2002 to 2005, the interstage mortality after a modified Norwood procedure was 7% in our
program. An interstage home monitoring program (HMP) was established to identify Norwood procedure
patients at increased risk of decompensation and to reduce interstage mortality.
Methods:Results of the first 5 years of the NorwoodHMPwere reviewed retrospectively. Interstagewas defined
as the time between Norwood hospital discharge and admission for second stage surgical palliation. In the HMP,
families documented oxygen saturation, heart rate, weight, and feedings daily. Nurse practitioners called each
family at least weekly, and when issues arose, action plans were determined based on symptom severity.
Results: Between October 2005 and October 2010 there were 46 Norwood procedure patients who survived to
hospital discharge. All were enrolled in the HMP. Forty-five patients had a Norwood procedure with right ven-
tricle to pulmonary artery conduit, and 1 patient had a modified Blalock-Taussig shunt. Interstage survival was
100%. Nineteen patients (41%) were admitted interstage; 5 patients were admitted twice, 1 patient was admit-
ted 4 times. Seventeen patients (37%) required interstage interventions. Eight patients (17%) required major
interventions: conduit stenting, aortic arch balloon angioplasty, emergent shunt, or early Glenn surgery. Minor
interventions included supplemental oxygen, blood transfusion, intravenous hydration, diuresis, anti-arrhythmic
therapy, or feeding adjustments.
Conclusions: In the first 5 years of the HMP, all infants discharged after a modified Norwood procedure survived
the interstage period. The HMP altered clinical management in 37% of patients. Home monitoring of oxygen
saturation, heart rate, weight, and feedings, along with comprehensive care coordination, allowed timely inter-
ventions and reduced interstage mortality from 7% to 0%. (J Thorac Cardiovasc Surg 2014;147:718-23)Supplemental material is available online.
By the late 1990s, early surgical survival from the Norwood
procedure for single-ventricle palliation reached 90% at
major centers, but interstage mortality after the Norwood
procedure with modified Blalock-Taussig shunt (mBTS) re-
mained at 7% to 15%.1-4 Although sudden interstage
deaths were a recognized phenomenon, no risk factors
had been identified.5-7 Proponents of the right ventricle to
pulmonary artery (RV-PA) conduit modification theorized
that this type of Norwood procedure might have lower
interstage mortality because there is no diastolic runoff
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The Journal of Thoracic and Cardiovascular Surgfrom 2002 to 2005, which was the largest series of RV-PA
conduit Norwood procedures performed at that time, there
was 7% interstage mortality.10 It was unclear at the time
whether the 7% interstage mortality represented a true im-
provement in comparison with the mBTS Norwood proce-
dure results or simply was within the previously reported
ranges. Subsequent larger series from several institutions,
which directly compared outcomes based on shunt types,
have found no significant difference in interstage sur-
vival.11-14 In the Single Ventricle Reconstruction Trial,
the mortality at 30 days after the Norwood procedure to
stage 2 surgery was 12% for RV-PA conduit Norwood pa-
tients and 22% for mBTS Norwood patients.15
In 2003, Ghanayem et al16 published the results of an in-
terstage home monitoring program for patients after under-
going the Norwood procedure with mBTS. All 36 infants
enrolled in the first 2 years survived the interstage period.
Amajority of those patients were re-admitted to the hospital
during the interstage period based on concerning home
monitoring trends and required interstage intervention.
In theory, the home monitoring program (HMP) allows
early detection of physiologic changes that put infants at
risk of decompensation, although no specific risk factors
were identified. The HMP also detected plateaus in growth,
which were interpreted as indicators of insufficientery c February 2014
Abbreviations and Acronyms
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LPCH ¼ Lucile Packard Children’s Hospital
mBTS ¼ modified Blalock-Taussig shunt
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NP ¼ nurse practitioner
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stage 2 surgery.17
Based on that report and our own findings of interstage
mortality in RV-PA conduit Norwood patients, we imple-
mented an interstage HMP for Norwood procedure patients
in 2005. The primary goal was to reduce interstage mortal-
ity rates. The hypothesis was that alterations in oxygen sat-
urations, failure to gain weight, or acute weight loss as
a result of dehydration may be signs of serious anatomic
lesions or other physiologic stressors and that early detec-
tion would permit life-saving intervention. This article pres-
ents results from 5 years of interstage home monitoring in
modified Norwood procedure patients with the RV-PA
conduit at the Lucile Packard Children’s Hospital
(LPCH), with specific attention to interstage mortality and
interventions to improve survival.METHODS
This retrospective, single-institution review was approved by the Insti-
tutional Review Board of the Stanford University School of Medicine. All
Norwood procedure patient information was extracted from the LPCH
electronic medical record, which included HMP correspondence and data.
Home Monitoring Program Methods and Resources
The Norwood HMP was established on October 1, 2005, and modeled
after the program at the Children’s Hospital of Wisconsin.16,18
Infants with hypoplastic left heart syndrome or other single-ventricle le-
sions with significant aortic arch obstruction requiring a Norwood proce-
dure were included in the HMP if they survived to hospital discharge,
irrespective of location of outpatient cardiologist follow-up evaluation,
proximity to LPCH, or primary language of the family. There was 100%
enrollment of eligible Norwood procedure patients.
Figure 1 summarizes the key components of the HMP. Patient identifi-
cation and HMP teaching with the family began in the cardiovascular inten-
sive care unit shortly after a Norwood procedure patient was extubated.
Each family received a Norwood Procedure Binder consisting of an expla-
nation of the HMP, diagram of Norwood anatomy, red flag indicators, im-
portant phone numbers, information for emergency medical providers, and
documentation sheets for daily entries. Red flag indicators are signs or
symptoms that, if present, should prompt an immediate call to the cardiol-
ogist or the HMP nurse practitioner (NP); these included oxygen saturation
less than 75%, weight loss of 30 g or more over a 2- to 3-day span or lack of
a 10- to 20-g weight gain over 3 days, respiratory distress, or fussiness. Pa-
tients were discharged with a pulse oximeter and a digital scale. Several
processes were put into place before discharge to optimize care coordina-
tion and continuity. A cardiac catheterization to assess Glenn surgical can-
didacy was scheduled at the patient’s 3-month birthday, regardless of the
patient’s age at Norwood discharge. The majority of these catheterizationsThe Journal of Thoracic and Cawere performed at LPCH, but this occurred at the discretion of the referring
cardiologist. A surgical date for the Glenn surgery also was scheduled, but
that date often was adjusted based on the patient’s status during the inter-
stage period or the results of the catheterization. The primary NP spoke di-
rectly with the pediatrician, and the HMP cardiologist communicated
directly with the outpatient cardiologist just before hospital discharge.
Throughout the interstage period, the parents recorded heart rate, oxy-
gen saturation, weight, and enteral intake once daily. Parents were promp-
ted to call if they noted any red flags, changes in trends of surveillance data,
or any symptoms they found atypical or concerning. Emphasis was placed
on trends and on a low threshold for calling the NP, rather than single data
points. Weekly phone calls from a primary NP tracked changes in clinical
status. Information from these calls was used in conjunction with assess-
ments by the primary cardiologist and pediatrician to adjust the medical
and nutritional regimen. Frequently, the HMP NP advanced the feedings
between clinic visits. When there were clinical concerns, either from the
parent or from the care team, or red flag criteria, an action plan was created.
Depending on the severity of the clinical concern, either HMP call fre-
quency was increased or the patient was seen by a clinician. Patients
were seen if there were true red flags, concern for new infection, fussiness,
or increased emesis with respiratory symptoms. This visit may have been
with the primary cardiologist or pediatrician, in the local Emergency
Department, or in the LPCHEmergency Department. Overall, clinical con-
cerns were presumed to be cardiac in nature until proven otherwise, and
there was a low threshold to have the patient seen whenever issues arose
throughout the interstage period. The only concerns that were addressed
solely with increased HMP call frequency were marginal weight gain,
slight weight loss with no other symptoms, or minor changes in frequency
of vomiting in patients with known reflux.
The HMP multidisciplinary team consists of cardiology NPs, a nurse
case manager, a nutritionist, and a single supporting cardiologist
(G.E.W.). At implementation, all of the personnel came from existing re-
sources within the Division of Pediatric Cardiology at LPCH. Over time,
some administrative time was needed for team communication, equipment
ordering, and program maintenance. Pulse oximeters were provided by
suppliers of durable medical equipment and for the most part were paid
for by the patient’s insurance after the HMP team submitted a letter of med-
ical necessity. Scales were paid for with charitable donations and were
returned by each family and used serially.
The patients received follow-up evaluation either with a community car-
diologist alone (for those who lived remotely), with a primary cardiologist
at LPCH (internal patients), or primary follow-up evaluation with the com-
munity cardiologist and at least one interstage visit with the HMP cardiol-
ogist at LPCH (regional patients). Throughout the interstage period, there
was frequent direct communication between the HMP team and commu-
nity cardiologists and pediatricians. Although families were encouraged
to call their primary cardiologist first about concerns (particularly if they
lived far from LPCH), many parents seemed to have a lower threshold
for calling the HMP NPs. In some cases, the primary care provider was in-
volved integrally, and in other scenarios the majority of the communication
was between the HMP team and the primary cardiologist. The basic com-
munication algorithm is summarized in Figure E1. There were many effec-
tive variations to this algorithm, but the emphasis was always on very close,
direct communication between the family, the HMP team, the primary car-
diologist, and the pediatrician. This communication was streamlined, but
there also was intentional overlap designed to provide the family constant
access to a provider familiar with their infant.RESULTS
During the first 5 years of the HMP from October 2005 to
October 2010, there were 46 infants enrolled. All eligible
patients who survived to hospital discharge after the modi-
fied Norwood procedure were enrolled. Interstage survivalrdiovascular Surgery c Volume 147, Number 2 719
FIGURE 1. Key components of HMP. HMP, Home monitoring program;
NP/PA, nurse practitioner/physician assistant; CVICU, cardiovascular
intensive care unit; PCARD, primary cardiologist; PMD, primary care
physician; HR, heart rate; O2 sats, oxygen saturations; ED, emergency
department; LPCH, Lucile Packard Children’s Hospital.
TABLE 1. Norwood HMP patient characteristics
Demographics No. of patients
Sex
Male 32 (70%)
Female 14 (30%)
Diagnosis
HLHS 37 (80%)
MA/AA 16
MS/AS 13
MS/AA 5
MA/AS 2
Critical AS 1
AVSD 3
DORV/MA/hypoplastic arch 2
Tricuspid atresia/hypoplastic arch 2
DILV 1
Prenatal diagnosis 35 (76%)
Age at Norwood procedure (d) 5 (1-37)
Weight at Norwood procedure (kg) 3.3 (2.4-4.1)
Age at Norwood discharge (d) 37 (15-95)
Weight at Norwood discharge (kg) 4 (2.6-4.9)
Length of postoperative ICU stay (d) 16.5 (9-59)
Length of postoperative hospital stay (d) 31 (12-83)
Duration of HMP (d) 76 (17-221)
Age at pre-Glenn surgery catheterization (d) 98 (64-172)
Age at Glenn surgery (d) 114 (73-254)
Weight at Glenn surgery (kg) 5.5 (3.9-7.5)
AA, Aortic atresia; AS, aortic stenosis; AVSD, atrioventricular septal defect; DILV,
double-inlet left ventricle; DORV, double-outlet right ventricle; HLHS, hypoplastic
left heart syndrome; ICU, intensive care unit;MA, mitral atresia;MS, mitral stenosis;
HMP, home monitoring program.
TABLE 2. Indications for interstage re-admissions
Indication No. of patients
Hypoxia 15
Growth failure
Inadequate intake 3
Emesis 3
Other
Respiratory distress 2
Tachyarrhythmia 1
Pericardial effusion 1
Positive blood culture 1
Hematochezia 1
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a total of 60 patients underwent Norwood procedure at
LPCH. Eleven patients died postoperatively before hospital
discharge (range, 3-98 days), and 3 patients remained
hospitalized until a successful Glenn surgery.
Table 1 displays the characteristics of the Norwood
procedure patients in the HMP. The predominant lesion
was hypoplastic left heart syndrome with mitral atresia
and aortic atresia. All but 1 patient underwent a modified
Norwood procedure with an RV-PA conduit. The other
patient had amodified Blalock-Taussig shunt because of un-
usual PA anatomy that precluded placement of an RV-PA
conduit. The median duration of interstage outpatient mon-
itoring was 76 days (range, 17-221 days). The outlier, who
was monitored for 221 days, had an interrupted inferior
vena cava and was monitored until a Kawashima surgery.
Of the 46 HMP patients, 25 were followed up solely by
a community cardiologist because they lived far from
LPCH, 15 were followed up internally at LPCH, and
6 regional patients were followed up by a community cardi-
ologist in conjunction with the HMP cardiologist.
NineteenHMPpatients (41%) had 27 readmissions during
the interstage period. Five patients were re-admitted twice
and 1 patient was re-admitted 4 times. The most common in-
dications for admission were hypoxemia (56%) and growth
failure (22%) (Table 2). Notably, no patient presented in
extremis, in shock, or in impending respiratory failure.
None had a cardiac arrest, renal failure, or stroke. Seven of
the 19 patients remained inpatients until the Glenn surgery.
Of the 19 patients re-admitted, 17 patients had either
major or minor interventions performed during the hospital-
ization, and only 2 patients were managed with observation720 The Journal of Thoracic and Cardiovascular Surgonly. Eight patients (17% of the HMP cohort) underwent
a major intervention, defined as unscheduled cardiac cathe-
terization or surgery (Table 3). The most common indica-
tion for intervention was RV-PA conduit stenosis, which
was addressed either with an early Glenn within several
days after catheterization (n ¼ 3) or with conduit stenting
(n ¼ 2). One other patient with conduit stenosis was
scheduled for early Glenn 2 days after catheterization but
developed profound acute hypoxemia on the night of
catheterization and underwent an emergent modified
Blalock-Taussig shunt. Aortic arch balloon angioplastyery c February 2014
TABLE 3. Interstage interventions
Major interventions No. of interventions
Cardiac catheterization
RV-PA conduit stent 2
Aortic arch balloon angioplasty 1
Change in surgical plan 1
Surgery
Early Glenn surgery 3
Shunt 1
Minor interventions No. of interventions
Supplemental oxygen 3
Intravenous therapy
Blood transfusion 3
Rehydration 3
Diuretics 1
Anti-arrhythmic 1
Adjustment of enteral feeds 2
RV-PA, Right ventricle to pulmonary artery.
FIGURE 2. Route of enteral feeding for HMP patients. GT, G tube;
PO, by mouth; NG, nasogastric.
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eventration and an abnormal left lung had multiple distal
PA stenoses, was deemed unsuitable for a Glenn surgery,
and was scheduled for surgical pulmonary arterioplasty.
Nine patients (20% of the HMP cohort) underwent minor
interventions during hospitalization including supplemental
oxygen administration, blood transfusion, intravenous fluid
or medications (diuretics, antibiotics, anti-arrhythmics), or
adjustment of enteral feedings (Table 3). Some patients
had more than 1 readmission and had 1 minor intervention
performed each time. Two patients required observation
only, 1 patient for hematochezia and 1 patient with influ-
enza B.
All HMP patients survived to second stage surgical palli-
ation. Forty-five patients (98%) underwent successful bidi-
rectional Glenn surgery. The patient with multiple distal
pulmonary artery stenoses who was unsuitable for a Glenn
surgery died after surgical pulmonary arterioplasty. There
were no perioperative Glenn deaths. There were 4 late
deaths after a Glenn surgery: 1 from a brain tumor, 1 from
heart failure, 1 with heart failure and presumed arrhythmia,
and 1 unexplained sudden death at home. One former HMP
patient underwent cardiac transplantation 7months after the
Glenn surgery. Twenty patients successfully completed
Fontan palliation, which typically is performed at 3 years
of age using an extracardiac conduit in our institution.19
In addition to the primary aim of improved interstage sur-
vival, the high level of HMP surveillance allowed for
a change in feeding management in our Norwood procedure
patients. In the absence of safety data, before the HMP, pa-
tients who could not establish growth with oral feedings
alone underwent gastrostomy tube placement. Concurrent
to the initiation of the HMP, we began discharging patients
with nasogastric (NG) tubes in combination with oral feeds,
unless patients were unable to protect their airway fromThe Journal of Thoracic and Cadirect aspiration or reflux (Figure 2). During the study pe-
riod in 2007, a retrospective review of laparoscopic gastro-
stomy procedures in Norwood patients from our institution
showed some morbidity, which substantiated the new man-
agement strategy.20 All patients were assessed initially for
oral feeding safety at the bedside by an occupational therapist
once NG feeding tolerance was established early after the
Norwood procedure. If the occupational therapist had con-
cerns, or if the patient had no audible voice, then further func-
tional evaluation occurred with a modified barium swallow.
Patients with aspiration by functional evaluation underwent
gastrostomy tube placement. Direct laryngoscopy was used
in some cases to assess vocal cord function but was not
used routinely. Parents were trained using teach-back
methods for all Norwood care including NG placement, per-
forming multiple directly supervised tube placements, and
using home equipment before discharge.
At discharge after the Norwood procedure, 17 patients
(37% of the HMP cohort) required NG tube feeding to
attain their caloric intake goal (Figure 2). There were no ad-
verse events associated with NG feeding. Notably, during
the interstage period, most patients had improved oral in-
take. Ten patients who were receiving tube feeds at the
time of Norwood procedure discharge transitioned to full
oral feeds by the time they were admitted for their Glenn
surgery. Only 8 patients (17% of the HMP cohort) required
a gastrostomy tube (n ¼ 3) or a gastrostomy tube/Nissen
fundoplication (n ¼ 5). Of these, 7 infants had vocal cord
paresis or paralysis documented by direct laryngoscopy
and were believed to be at risk of aspiration.
Active attention to interstage growth was an important
part of the HMP. The median weight of the HMP cohort
at Glenn surgery was 5.5 kg (range, 3.9-7.5 kg) at a median
age of 114 days (range, 73-254 days).DISCUSSION
In 2005, an interstage HMP was established for Norwood
procedure patients. Through the first 5 years of the HMP,rdiovascular Surgery c Volume 147, Number 2 721
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were re-admitted during the interstage period, but none pre-
sented with cardiac arrest, shock, impending respiratory
failure, renal failure, or stroke. This is a substantial reduc-
tion in interstage mortality and morbidity compared with
prior single-center and multicenter reports.11,13-15,21,22
Ghanayem et al16 previously showed a survival benefit
with HMP in Norwood procedure patients with a modified
Blalock-Taussig shunt. Our results also confirm that home
monitoring reduces interstage mortality in patients under-
going a modified Norwood procedure with an RV-PA
conduit.
The goal of the HMP is to identify physiologic distur-
bances before decompensation and to provide an early
warning system to allow for timely interventions. In our
cohort, this approach successfully prevented major
decompensations: there were no deaths, cardiac arrests, or
respiratory failures. However, 37% of patients required in-
terstage interventions, which were triggered by concerns
raised by the HMP. Seventeen percent required major inter-
ventions, defined as unscheduled interventional catheteriza-
tion or surgery. The percentage of patients requiring such
intervention was remarkably close to previously reported
interstage mortality rates. The patients who underwent ma-
jor interventions may represent near-miss deaths; if so,
early identification of anatomic or physiologic abnormali-
ties via the HMP has reduced mortality.
Among this fragile population, it also was notable that
many patients were re-admitted during the interstage pe-
riod; however, only 2 patients were admitted just for obser-
vation. This suggests that admissions were not prompted
simply by heightened parental anxiety or overly conserva-
tive practice by the HMP team. Rather, the availability of
oxygen saturation and growth data trends often substanti-
ated parental observations and enhanced decision making
by the clinical team.
It is not clear from these findings whether improved
survival is the result of closer assessment of physiologic
variables, intensified care coordination, or a combination
of both of these factors. The HMP is a complex care model
that facilitates communication between the family and all
clinical providers. A team of multidisciplinary providers
works together closely to care for these infants at home. In
our experience, because of the surveillance calls, there was
a lower threshold for contact between parents and the HMP
NPs. There also was tighter coordination between commu-
nity cardiologists and the surgical site and a smoother transi-
tion from inpatient to outpatient care. When issues arise, the
HMP is an additional resource for the family or emergency
providers at times when a local cardiologist or pediatrician
may be unavailable. The Norwood procedure HMP is
a model that has far-reaching implications in the care of chil-
dren with chronic diseases to ensure multidisciplinary care
coordination outside the hospital across pediatric specialties.722 The Journal of Thoracic and Cardiovascular SurgAn intact atrial septum, older age at surgery, periopera-
tive arrhythmias, airway complications, and decreased ven-
tricular function at hospital discharge have been reported as
risk factors for interstage death in Norwood procedure pa-
tients.21,22 In our cohort, specific physiologic risk factors
for re-admission or intervention could not be defined. How-
ever, in response to lessons learned from re-admissions dur-
ing the first 2 years, a number of changes were made in the
HMP. Based on several patients needing urgent unplanned
catheterizations early in the experience as a result of cyano-
sis from conduit stenosis, the HMP tried to schedule the
pre-Glenn surgery catheterization at the patient’s 3-month
birthday (regardless of patient age at Norwood procedure
discharge). Although we anticipated some variability, to
our surprise, all patients except the patient with the dia-
phragm eventration have had acceptably low pulmonary
vascular resistance by 3 months of age to be eligible for
Glenn surgery. Thus, since 2006, all patients have been
scheduled for elective catheterization at 3 months of age.
In response to gaps in care in the transition home, the
HMP began setting up the pre-Glenn surgery catheteriza-
tion date before Norwood procedure hospital discharge.
After the catheterization, the timing of the Glenn surgery
then is determined based on the patient’s clinical status. If
the patient persistently has oxygen saturation levels less
than 70% or has plateaued in growth, then the patient is
put forward at that time for surgery. Otherwise, the patient
is continued in the HMP and scheduled at about 4 months of
age or when the cardiologist and surgeon think surgery is
indicated clinically.
The programmatic change in timing of the elective cath-
eterization may have contributed to improved interstage
survival by decreasing the duration of the interstage period.
Before the HMP, from 2002 to 2005, the mean age at pre-
Glenn surgery catheterization for Norwood procedure pa-
tients was 126 days and the mean age at bidirectional Glenn
surgery was 151 days.10 From 2005 to 2010, the mean age at
catheterization was 99 days and the mean age at Glenn sur-
gery was 118 days. Anecdotally, no increase in periopera-
tive Glenn surgery morbidity has been noted, although
this was not studied formally in this cohort.
Early on, there was a trend toward more re-admissions in
patients who lived farther than an hour away from LPCH
and in patients whose families were not native English
speakers. Surveillance was heightened for the remote
patients by more direct contact by the HMP team with the
local pediatrician as well as the community cardiologist.
Initially, we thought it would be difficult to make this pro-
gram work for remote patients, but over time it seems that
these patients may be a subset for whom the care coordina-
tion piece has been especially helpful, perhaps because the
family is more dependent on the local primary care provider
and the HMP team is an additional cardiology resource.
For the non-English speaking families, the program wasery c February 2014
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their language (which was predominantly Spanish in our
population).
Although the primary aim of the HMP was to improve
survival, a secondary benefit was that the high level of sur-
veillance allowed for a change in feeding management.
With initiation of the HMP, there was a shift away from gas-
trostomy tubes toward NG tubes for patients who could not
maintain weight gain with oral feedings alone. In our expe-
rience, NG feeding has been safe and effective. Not only
were there no adverse events associated with NG tubes,
but additionally this practice allowed many infants to tran-
sition to full oral feeds before the Glenn surgery. Currently,
in our practice, gastrostomy tubes, usually with Nissen fun-
doplication, are reserved for the small minority of patients
who cannot protect their airway based on functional evalu-
ation with a modified barium swallow. Active attention to
interstage growth is an important part of the HMP.
In summary, interstage home monitoring has improved
survival of modified Norwood patients. However, approxi-
mately 40% must be re-admitted to the hospital during
the interstage period. The ultimate goal of the HMP will
be to maintain high interstage survival with shorter inpatient
hospitalizations and less interstage re-admissions. Efforts
currently are underway in the multicenter National Pediat-
ric Cardiology Quality Improvement Collaborative to refine
predictors of risk for individual patients and to identify spe-
cific practices associated with improved interstage survival
and lower admission rates.23-25
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FIGURE E1. When there were clinical concerns from either the parent or
the NP, an action plan was created. Depending on the severity of the con-
cern, the patient was seen by a clinician or the HMP call frequency was in-
creased. Overall, symptoms were presumed to be cardiac in nature until
proven otherwise, and there was a low threshold to have the patient seen
whenever any issues arose throughout the interstage period. Patients
were sent to their primary cardiologist’s office for most problems, but there
were many effective variations to this algorithm. In some cases, the primary
care provider was involved integrally, and in other scenarios the majority of
communication occurred between the HMP team and the primary cardiol-
ogist. The emphasis was always on very close, direct communication be-
tween the family, the HMP team, the primary cardiologist, and the
pediatrician. The HMP NPs documented all calls in the LPCH electronic
medical record, so concerns and plans were accessible to all HMP team
members and to on-call cardiology fellows. NP, Nurse practitioner;
HMP, home monitoring program; GERD, gastroesophageal reflux disease;
ED, emergency department.
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